Know Cancer

or
forgot password

Health Status and Quality of Life in Patients With Early Stage Hodgkin's Disease: A Companion Study to SWOG-9133


N/A
18 Years
N/A
Not Enrolling
Both
Lymphoma, Psychosocial Effects of Cancer and Its Treatment

Thank you

Trial Information

Health Status and Quality of Life in Patients With Early Stage Hodgkin's Disease: A Companion Study to SWOG-9133


OBJECTIVES: I. Evaluate prospectively the health status and quality of life of patients with
Stage I/IIA Hodgkin's disease randomized on protocol SWOG-9133 (CLB-9391) to treatment with
subtotal nodal irradiation with vs. without 3 courses of doxorubicin/vinblastine. II.
Describe the short-term effects of these treatments on these patients and compare their
impact on quality of life (i.e., patient symptom status, health status, fatigue). III.
Evaluate the intermediate and long-term effects of these treatments on these patients and
compare their impact on quality-of-life outcomes over 5 years.

OUTLINE: Quality-of-Life Assessment. Cancer Rehabilitation Evaluation System Short Form,
CARES-SF; Symptom and Personal Information Questionnaire (including Symptom Distress Scale,
MOS SF-36 Fatigue Scale, MOS SF-36 Health Perception Rating, Demographics); Cover Sheet.

PROJECTED ACCRUAL: Approximately 500 patients will be accrued over 7 years.

Inclusion Criteria


DISEASE CHARACTERISTICS: Patients must be eligible for and registered to SWOG-9133

PATIENT CHARACTERISTICS: Patients must be able to complete the questionnaires in English.
If they are not able to complete questionnaires in English, patients may be registered to
SWOG-9133 without participating in SWOG-9208.

The Symptom and Personal Information Questionnaire #1, the Cancer Rehabilitation
Evaluation System Short Form (CARES-SF) and Cover Sheet must be completed prior to
registration and randomization on SWOG-9133.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Patricia A. Ganz, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Jonsson Comprehensive Cancer Center

Authority:

United States: Federal Government

Study ID:

CDR0000063515

NCT ID:

NCT00002563

Start Date:

April 1994

Completion Date:

May 2005

Related Keywords:

  • Lymphoma
  • Psychosocial Effects of Cancer and Its Treatment
  • stage I adult Hodgkin lymphoma
  • stage II adult Hodgkin lymphoma
  • psychosocial effects of cancer and its treatment
  • Hodgkin Disease
  • Lymphoma

Name

Location

Roswell Park Cancer InstituteBuffalo, New York  14263
Walter Reed Army Medical CenterWashington, District of Columbia  20307-5000
University of Iowa Hospitals and ClinicsIowa City, Iowa  52242
University of Massachusetts Memorial Medical CenterWorcester, Massachusetts  01655
Comprehensive Cancer Center of Wake Forest University Baptist Medical CenterWinston-Salem, North Carolina  27157-1082
Rhode Island HospitalProvidence, Rhode Island  02903
Ellis Fischel Cancer Center - ColumbiaColumbia, Missouri  65203
Barnes-Jewish HospitalSaint Louis, Missouri  63110
State University of New York - Upstate Medical UniversitySyracuse, New York  13210
University of Tennessee, Memphis Cancer CenterMemphis, Tennessee  38103
Beth Israel Medical CenterNew York, New York  10003